We are live on !
Find out more
JDR
Jay D. Rosenbaum Portfolio holdings
AUM
$6.69M
Turnover
80%
1-Year Est. Return
4.68%
This Fund
S&P 500
This Quarter Est. Return
-4.04%
1 Year Est. Return
+4.68%
3 Year Est. Return
+12.92%
5 Year Est. Return
+74.65%
10 Year Est. Return
+173.05%
AUM
$447M
AUM Growth
-$19.9M
(-4.3%)
Cap. Flow
-$990K
Cap. Flow % of AUM
Cap. Flow %
-0.22%
Top 10 Holdings %
Top 10 Hldgs %
95.29%
Holding
41
New
–
Increased
–
Reduced
8
Closed
1
Avg Time Held
0.5
years
Top 10 Avg Time Held
0.5
years
Top 20 Avg Time Held
0.5
years
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$353K |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$210K |
| 3 |
Procter & Gamble
PG
|
+$137K |
| 4 |
IBM
IBM
|
+$67.2K |
| 5 |
Qualcomm
QCOM
|
+$61.4K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 93.23% |
| 2 | Healthcare | 2.26% |
| 3 | Technology | 2% |
| 4 | Consumer Staples | 0.68% |
| 5 | Industrials | 0.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
RICE
1
DELISTED
Rice Energy Inc.
RICE
| $412M | 92.24% |
19,800,000
| – | – |
2014 Q4
2 quarters
|
|
2
Amgen
AMGN
$249B
| $1.86M | 0.42% |
12,086
-354
| -3% | -$56.7K |
2014 Q4
2 quarters
|
|
3
Intel
INTC
$299B
| $1.85M | 0.41% |
60,678
-1,758
| -3% | -$56.8K |
2014 Q4
2 quarters
|
|
4
Abbott
ABT
$190B
| $1.72M | 0.39% |
35,100
| – | – |
2014 Q4
2 quarters
|
|
5
Edwards Lifesciences
EW
$58.7B
| $1.54M | 0.34% |
64,950
| – | – |
2014 Q4
2 quarters
|
|
6
Apple
AAPL
$4.98T
| $1.46M | 0.33% |
46,600
| – | – |
2014 Q4
2 quarters
|
|
|
7
Procter & Gamble
PG
$383B
| $1.4M | 0.31% |
17,911
-1,704
| -9% | -$137K |
2014 Q4
2 quarters
|
|
|
8
State Street SPDR S&P 500 ETF Trust
SPY
$777B
| $1.33M | 0.3% |
6,460
-1,000
| -13% | -$210K |
2014 Q4
2 quarters
|
|
9
Johnson & Johnson
JNJ
$665B
| $1.25M | 0.28% |
12,850
| – | – |
2014 Q4
2 quarters
|
|
10
Stryker
SYK
$124B
| $1.24M | 0.28% |
12,996
| – | – |
2014 Q4
2 quarters
|
|
11
Emerson Electric
EMR
$90.6B
| $1.21M | 0.27% |
21,890
| – | – |
2014 Q4
2 quarters
|
|
12
Microsoft
MSFT
$3.94T
| $1.14M | 0.26% |
25,860
-500
| -2% | -$22.8K |
2014 Q4
2 quarters
|
|
13
PepsiCo
PEP
$193B
| $1.14M | 0.25% |
12,205
| – | – |
2014 Q4
2 quarters
|
|
14
Medtronic
MDT
$130B
| $1.08M | 0.24% |
14,600
| – | – |
2014 Q4
2 quarters
|
|
|
BHI
15
DELISTED
Baker Hughes
BHI
| $1.06M | 0.24% |
17,100
| – | – |
2014 Q4
2 quarters
|
|
16
ExxonMobil
XOM
$677B
| $1.04M | 0.23% |
12,447
| – | – |
2014 Q4
2 quarters
|
|
|
RDS.B
17
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $1.02M | 0.23% |
17,715
| – | – |
2014 Q4
2 quarters
|
|
|
18
Qualcomm
QCOM
$177B
| $981K | 0.22% |
15,660
-900
| -5% | -$61.4K |
2014 Q4
2 quarters
|
|
19
JPMorgan Chase
JPM
$888B
| $978K | 0.22% |
14,425
| – | – |
2014 Q4
2 quarters
|
|
20
3M
MMM
$95.5B
| $962K | 0.22% |
7,456
| – | – |
2014 Q4
2 quarters
|
|
21
TJX Companies
TJX
$149B
| $941K | 0.21% |
28,450
| – | – |
2014 Q4
2 quarters
|
|
|
XLNX
22
DELISTED
Xilinx Inc
XLNX
| $928K | 0.21% |
21,025
| – | – |
2014 Q4
2 quarters
|
|
23
CVS Health
CVS
$107B
| $791K | 0.18% |
7,550
| – | – |
2014 Q4
2 quarters
|
|
24
US Bancorp
USB
$92.6B
| $752K | 0.17% |
17,325
| – | – |
2014 Q4
2 quarters
|
|
25
Cognizant
CTSH
$28.9B
| $686K | 0.15% |
11,225
| – | – |
2014 Q4
2 quarters
|
|
Similar funds
KIM
HVM
Jay D. Rosenbaum's Q2 2015 Portfolio in Review
As of Q2 2015, Jay D. Rosenbaum held 41 positions worth $447M, down 4.3% from $467M the previous quarter. Its ten largest holdings account for 95% of the portfolio.
Trading was light in Q2 2015: portfolio turnover was 2.4%. Jay D. Rosenbaum opened no new positions and exited 1, leaving the 41-position portfolio largely intact.
By sector, the portfolio is most concentrated in Energy at 93% of assets, up from 93% a quarter earlier, followed by Healthcare and Technology.
- Jay D. Rosenbaum's biggest Q2 2015 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $210K.
- Jay D. Rosenbaum fully exited Thermo Fisher Scientific in Q2 2015, selling an estimated $353K.
- Jay D. Rosenbaum's ten largest holdings make up 95% of its $447M portfolio in Q2 2015.
- Jay D. Rosenbaum opened 0 new positions and closed 1 in Q2 2015.
- Jay D. Rosenbaum's portfolio value fell 4.3% quarter-over-quarter to $447M.
Based on Jay D. Rosenbaum's 13F filing for Q2 2015, filed 8 Jul 2015.